Patent details

Basic Information

Publication number:

EP2282770

PCT Application Number:

US2009046214

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP098149297

PCT Publication Number:

WO2010033279

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODIES WITH ALTERED BINDING TO FCRN AND METHODS OF USING SAME

French Title of Invention:

ANTICORPS À LIAISON ALTEREE À FCRN ET LEURS PROCEDES D'UTILISATION

German Title of Invention:

ANTIKÖRPER MIT VERÄNDERTER BINDUNG AN FCRN UND VERWENDUNGSVERFAHREN DAFÜR

SPC Number:

Dates

Filing date:

04/06/2009

Grant date:

07/03/2018

EP Publication Date:

16/02/2011

PCT Publication Date:

25/03/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/03/2018

EP B1 Publication Date:

07/03/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/06/2018

Expiration date:

04/06/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

28/02/2018

 

 

Name:

MacroGenics, Inc.

Address:

9704 Medical Center Drive, Rockville, MD 20850, United States (US)

Inventor

Name:

GORLATOV, Sergey

Address:

United States (US)

Priority

Priority Number:

58658 P

Priority Date:

04/06/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; C07K 16/00;

Publication

European Patent Bulletin

Issue number:

201810

Publication date:

07/03/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1